Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-22

Clinical Trial Update: Antibiotic Impregnated Bone Graft to Reduce Infection in Hip Replacement. [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial is evaluating an antibiotic-impregnated bone graft to reduce infections in hip replacement surgery, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antibiotic-impregnated bone graft

Snippet

Sponsor: University Hospital, Linkoeping | Conditions: Arthroplasty, Replacement, Hip, Osteoarthritis, Hip | Phase 2, Phase 3 | Status: RECRUITING